Sinotherapeutics INC.

Founded in 2012 and now listed on China's STAR Market, Sinotherapeutics provides one-stop formulation development CRO and CDMO services for new drug candidates, built on established, advanced formulation R&D and manufacturing platforms. Its headquarters and R&D center are located in Shanghai with well-equipped formulation and analytical labs, while its manufacturing site in Jiangsu has been inspected multiple times by the US FDA and China's NMPA, with an excellent track record providing services from pre-clinical through commercialization stages.